Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | CASP6 | P55212 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10460624 | 0.81 | MAOA (0.47) | KMT2AMEN1MAOAMAOBHPGD | |
| SCHEMBL1672615 | 0.80 | MAOA (0.59) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL4427203 | 0.78 | MAOA (0.61) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL11474820 | 0.76 | PTGS2 (0.43) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL5658039 | 0.75 | MAOA (0.41) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL11476389 | 0.74 | KDM4E (0.39) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL5657956 | 0.74 | CYP19A1 (0.47) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL7110536 | 0.74 | PSMB5 (0.49) | MAOAMAOBKDM4EATMMAPT | |
| SCHEMBL7110728 | 0.73 | PTGS2 (0.43) | KMT2AMEN1MAOAMAOBALDH1A1 | |
| SCHEMBL16801094 | 0.72 | KDM4E (0.44) | KDM4ECASP3SENP8SENP7SENP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108623-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120108623-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120108623-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110105552-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110105552-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110105552-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-7829576-B2 | Beloxepin and analogs for the treatment of pain | ADOLOR CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-7829576-B2 | Beloxepin and analogs for the treatment of pain | ADOLOR CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-7829576-B2 | Beloxepin and analogs for the treatment of pain | ADOLOR CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-20100173927-A1 | administering 2,3,4,4a,13b-hexahydro-2,10-dimethyldiben-[2,3:6,7]oxepino[4,5c]pyridine-4a-ol] for treating pain associated with surgery, inflammation, cancer and neuropathic pain; pain management | ADOLOR CORPORATION (US) | 2010-07-08 | — | — | US | disclosed |
| US-20090233957-A1 | (-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233957-A1 | (-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233957-A1 | (-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233959-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233959-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233959-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233958-A1 | (+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233958-A1 | (+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| US-20090233958-A1 | (+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | ADOLOR CORPORATION (US) | 2009-09-17 | — | — | US | disclosed |
| WO-2009105507-A2 | BELOXEPIN, ITS ENANTIOMERS, AND ANALOGS THEREOF FOR THE TREATMENT OF PAIN | ADOLOR CORPORATION (US) | 2009-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173927-A1 | administering 2,3,4,4a,13b-hexahydro-2,10-dimethyldiben-[2,3:6,7]oxepino[4,5c]pyridine-4a-ol] for treating pain associated with surgery, inflammation, cancer and neuropathic pain; pain management | OPRL1, OPRK1, OPRM1 | KMT2A 1393/4885MEN1 3538/4885MAOA 2408/4885 |
| US-20090233959-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | OPRL1, LPXN, OPRK1 | KMT2A 2760/4885MEN1 4378/4885MAOA 2720/4885 |
| US-20090233957-A1 | (-)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | BCHE, LOX, NAPEPLD | KMT2A 3975/4885MEN1 2381/4885MAOA 720/4885 |
| US-20120108623-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | OPRL1, LPXN, OPRK1 | KMT2A 2760/4885MEN1 4378/4885MAOA 2720/4885 |
| US-20090233958-A1 | (+)-BELOXEPIN AND METHODS FOR ITS SYNTHESIS AND USE | BCHE, ACHE, LOX | KMT2A 4143/4885MEN1 2128/4885MAOA 558/4885 |
| US-20110105552-A1 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN | OPRL1, LPXN, OPRK1 | KMT2A 2760/4885MEN1 4378/4885MAOA 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.